The TB structural genomics consortium crystallization facility: towards automation from protein to electron density.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMID 12351851)

Published in Acta Crystallogr D Biol Crystallogr on September 26, 2002

Authors

Bernhard Rupp1, Brent W Segelke, Heike I Krupka, Tim Lekin, Johana Schäfer, Adam Zemla, Dominique Toppani, Gyorgy Snell, Thomas Earnest

Author Affiliations

1: Macromolecular Crystallography and TB Structural Genomics Consortium, Lawrence Livermore National Laboratory, Livermore, CA 94551, USA. br@llnl.gov

Articles citing this

PubNet: a flexible system for visualizing literature derived networks. Genome Biol (2005) 2.89

MrBUMP: an automated pipeline for molecular replacement. Acta Crystallogr D Biol Crystallogr (2007) 2.16

Trace fluorescent labeling for high-throughput crystallography. Acta Crystallogr D Biol Crystallogr (2006) 1.53

Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery. Trends Microbiol (2010) 1.16

Developing a Fluorescence-based Approach to Screening for Macromolecule Crystallization Conditions. Cryst Growth Des (2011) 0.90

Cloning, expression, purification, crystallization and preliminary X-ray studies of epoxide hydrolases A and B from Mycobacterium tuberculosis. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.87

Applications of the second virial coefficient: protein crystallization and solubility. Acta Crystallogr F Struct Biol Commun (2014) 0.85

The molecular structure of Rv2074, a probable pyridoxine 5'-phosphate oxidase from Mycobacterium tuberculosis, at 1.6 angstroms resolution. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.84

Automated harvesting and processing of protein crystals through laser photoablation. Acta Crystallogr D Struct Biol (2016) 0.82

Lessons from ten years of crystallization experiments at the SGC. Acta Crystallogr D Struct Biol (2016) 0.81

REdiii: a pipeline for automated structure solution. Acta Crystallogr D Biol Crystallogr (2015) 0.75

Current awareness on comparative and functional genomics. Comp Funct Genomics (2003) 0.75

Articles by these authors

A phylogeny-driven genomic encyclopaedia of Bacteria and Archaea. Nature (2009) 15.06

Critical assessment of methods of protein structure prediction (CASP)-round V. Proteins (2003) 5.88

Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure (2004) 3.31

A polymeric protein anchors the chromosomal origin/ParB complex at a bacterial cell pole. Cell (2008) 3.15

From words to literature in structural proteomics. Nature (2003) 2.80

Comparative genomics tools applied to bioterrorism defence. Brief Bioinform (2003) 2.44

Assessment of progress over the CASP experiments. Proteins (2003) 2.43

The other 90% of the protein: assessment beyond the Calphas for CASP8 template-based and high-accuracy models. Proteins (2009) 2.43

Dapper, a Dishevelled-associated antagonist of beta-catenin and JNK signaling, is required for notochord formation. Dev Cell (2002) 2.28

Automated sample mounting and alignment system for biological crystallography at a synchrotron source. Structure (2004) 2.00

Antibody elbow angles are influenced by their light chain class. J Mol Biol (2006) 1.96

Community genomic and proteomic analyses of chemoautotrophic iron-oxidizing "Leptospirillum rubarum" (Group II) and "Leptospirillum ferrodiazotrophum" (Group III) bacteria in acid mine drainage biofilms. Appl Environ Microbiol (2009) 1.86

Structural basis for recognition of acidic-cluster dileucine sequence by GGA1. Nature (2002) 1.84

The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. Proc Natl Acad Sci U S A (2005) 1.67

Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein. J Biol Chem (2011) 1.61

The crystal structures of EAP domains from Staphylococcus aureus reveal an unexpected homology to bacterial superantigens. J Biol Chem (2005) 1.37

Cell-free co-expression of functional membrane proteins and apolipoprotein, forming soluble nanolipoprotein particles. Mol Cell Proteomics (2008) 1.25

Structural genomics of pathogenic protozoa: an overview. Methods Mol Biol (2008) 1.20

Structural characterization of autoinhibited c-Met kinase produced by coexpression in bacteria with phosphatase. Proc Natl Acad Sci U S A (2006) 1.18

Crystal Structure of AhpE from Mycobacterium tuberculosis, a 1-Cys peroxiredoxin. J Mol Biol (2005) 1.11

The high-speed Hydra-Plus-One system for automated high-throughput protein crystallography. Acta Crystallogr D Biol Crystallogr (2002) 1.07

Different apolipoproteins impact nanolipoprotein particle formation. J Am Chem Soc (2007) 1.06

Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent. Proc Natl Acad Sci U S A (2008) 1.03

Characterization of cytochrome 579, an unusual cytochrome isolated from an iron-oxidizing microbial community. Appl Environ Microbiol (2008) 1.03

Atomic force microscopy differentiates discrete size distributions between membrane protein containing and empty nanolipoprotein particles. Biochim Biophys Acta (2008) 1.02

A semi-quantitative, synteny-based method to improve functional predictions for hypothetical and poorly annotated bacterial and archaeal genes. PLoS Comput Biol (2011) 1.02

Quantifying size distributions of nanolipoprotein particles with single-particle analysis and molecular dynamic simulations. J Lipid Res (2008) 1.01

Extending X-ray crystallography to allow the imaging of noncrystalline materials, cells, and single protein complexes. Annu Rev Phys Chem (2008) 1.00

Concanavalin A in a dimeric crystal form: revisiting structural accuracy and molecular flexibility. Acta Crystallogr D Biol Crystallogr (2002) 0.98

The structure and computational analysis of Mycobacterium tuberculosis protein CitE suggest a novel enzymatic function. J Mol Biol (2006) 0.98

Structural basis for iron binding and release by a novel class of periplasmic iron-binding proteins found in gram-negative pathogens. J Bacteriol (2004) 0.95

Cell-free expression for nanolipoprotein particles: building a high-throughput membrane protein solubility platform. Methods Mol Biol (2009) 0.93

Mycobacterium tuberculosis RmlC epimerase (Rv3465): a promising drug-target structure in the rhamnose pathway. Acta Crystallogr D Biol Crystallogr (2004) 0.92

The role of viral population diversity in adaptation of bovine coronavirus to new host environments. PLoS One (2013) 0.92

Amino acid and structural variability of Yersinia pestis LcrV protein. Infect Genet Evol (2009) 0.90

Crystal structure of Pasteurella haemolytica ferric ion-binding protein A reveals a novel class of bacterial iron-binding proteins. J Biol Chem (2003) 0.90

Selective high-affinity ligand antibody mimics for cancer diagnosis and therapy: initial application to lymphoma/leukemia. Clin Cancer Res (2007) 0.88

Immobilization of His-tagged proteins on nickel-chelating nanolipoprotein particles. Bioconjug Chem (2009) 0.88

Crystal structure of a putative pyridoxine 5'-phosphate oxidase (Rv2607) from Mycobacterium tuberculosis. Proteins (2006) 0.88

A non-cleavable UmuD variant that acts as a UmuD' mimic. J Biol Chem (2006) 0.88

Advanced beamline automation for biological crystallography experiments. Acta Crystallogr D Biol Crystallogr (2006) 0.87

Crystal structures and proposed structural/functional classification of three protozoan proteins from the isochorismatase superfamily. Protein Sci (2005) 0.85

An extracellular disulfide bond forming protein (DsbF) from Mycobacterium tuberculosis: structural, biochemical, and gene expression analysis. J Mol Biol (2010) 0.84

Isolation, characterization, and stability of discretely-sized nanolipoprotein particles assembled with apolipophorin-III. PLoS One (2010) 0.83

The significance of performance ranking in CASP--response to Marti-Renom et al. Structure (2002) 0.83

Structure of pyrR (Rv1379) from Mycobacterium tuberculosis: a persistence gene and protein drug target. Acta Crystallogr D Biol Crystallogr (2005) 0.82

Structure of Rv1848 (UreA), the Mycobacterium tuberculosis urease gamma subunit. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.82

Characterization and purification of polydisperse reconstituted lipoproteins and nanolipoprotein particles. Int J Mol Sci (2009) 0.82

Laboratory scale structural genomics. J Struct Funct Genomics (2004) 0.81

Structural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-IIalpha. Protein Sci (2002) 0.78

A strain of Yersinia pestis with a mutator phenotype from the Republic of Georgia. FEMS Microbiol Lett (2013) 0.78

Structure of Mycobacterium tuberculosis RuvA, a protein involved in recombination. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.78

Synchrotron-based X-ray-sensitive nanoprobes for cellular imaging. Adv Mater (2014) 0.76

Design, synthesis, and structure-activity relationships of spirolactones bearing 2-ureidobenzothiophene as acetyl-CoA carboxylases inhibitors. Bioorg Med Chem Lett (2011) 0.76

SpaK/SpaR two-component system characterized by a structure-driven domain-fusion method and in vitro phosphorylation studies. PLoS Comput Biol (2009) 0.75

Discovery of a B-cell lymphoma 6 Protein-Protein Interaction Inhibitor by a Biophysics-driven Fragment-based Approach. J Med Chem (2017) 0.75

Identification of a thermo-regulated glutamine-binding protein from Yersinia pestis. Protein Pept Lett (2008) 0.75

Practical applications of structural genomics technologies for mutagen research. Mutat Res (2010) 0.75

Efficient macromolecular crystallization using microfluidics and randomized design of screening reagents. Methods Mol Biol (2008) 0.75